Comparing treatments using quality-adjusted survival: The q-twist method

Richard D. Gelber, Bernard F. Cole, Shari Gelber, Aron Goldhirsch

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

The quality of life of patients is an important component of evaluation of therapies. We present an overview of a statistical method called Q-TWiST (Quality-Adjusted Time Without Symptoms and Toxicity) which incorporates quality-of-life considerations into treatment comparisons. Multivariate censored survival data are used to partition the overall survival time into periods of time spent in a set of progressive clinical health states which may differ in quality of life. Mean health state durations, restricted to the follow-up limits of the clinical trial, are derived from the data and combined with value weights to estimate quality- adjusted survival. The methodology emphasizes treatment comparisons based on threshold utility analyses that high-light trade-offs between different health state durations; it is not intended to provide a unique result combining quality and quantity of life. We also describe three recent ex-tensions of the methodology: Covariates can be included using proportional hazards and accelerated failure time regression models, restricted estimates can be projected beyond follow-up limits using parametric models, and meta-analyses can be performed incorporating quality-of- life dimensions. The basic methods are demonstrated in an analysis of data from a clinical trial comparing long versus short duration adjuvant chemotherapy regimens for the treatment of breast cancer. The clinical health states are defined by the following three outcomes: (1) end of treatment toxicity, (2) disease recurrence, and (3) death. The results allow one to evaluate the trade-off between the increased toxic effects and the increased recurrence-free interval associated with the long duration treatment.

Original languageEnglish
Pages (from-to)161-169
Number of pages9
JournalAmerican Statistician
Volume49
Issue number2
DOIs
Publication statusPublished - 1995

Fingerprint

Twist
Quality of Life
Health
Toxicity
Clinical Trials
Recurrence
Trade-offs
Accelerated Failure Time Model
Censored Survival Data
Proportional Hazards
Methodology
Survival Time
Chemotherapy
Parametric Model
Breast Cancer
Period of time
Estimate
Statistical method
Therapy
Covariates

Keywords

  • Clinical trials
  • Quality of life
  • Restricted means
  • Survival analysis
  • Utility

ASJC Scopus subject areas

  • Mathematics(all)
  • Statistics and Probability
  • Statistics, Probability and Uncertainty

Cite this

Comparing treatments using quality-adjusted survival : The q-twist method. / Gelber, Richard D.; Cole, Bernard F.; Gelber, Shari; Goldhirsch, Aron.

In: American Statistician, Vol. 49, No. 2, 1995, p. 161-169.

Research output: Contribution to journalArticle

Gelber, Richard D. ; Cole, Bernard F. ; Gelber, Shari ; Goldhirsch, Aron. / Comparing treatments using quality-adjusted survival : The q-twist method. In: American Statistician. 1995 ; Vol. 49, No. 2. pp. 161-169.
@article{e1b6aaffae4e42cb867adbab325595c7,
title = "Comparing treatments using quality-adjusted survival: The q-twist method",
abstract = "The quality of life of patients is an important component of evaluation of therapies. We present an overview of a statistical method called Q-TWiST (Quality-Adjusted Time Without Symptoms and Toxicity) which incorporates quality-of-life considerations into treatment comparisons. Multivariate censored survival data are used to partition the overall survival time into periods of time spent in a set of progressive clinical health states which may differ in quality of life. Mean health state durations, restricted to the follow-up limits of the clinical trial, are derived from the data and combined with value weights to estimate quality- adjusted survival. The methodology emphasizes treatment comparisons based on threshold utility analyses that high-light trade-offs between different health state durations; it is not intended to provide a unique result combining quality and quantity of life. We also describe three recent ex-tensions of the methodology: Covariates can be included using proportional hazards and accelerated failure time regression models, restricted estimates can be projected beyond follow-up limits using parametric models, and meta-analyses can be performed incorporating quality-of- life dimensions. The basic methods are demonstrated in an analysis of data from a clinical trial comparing long versus short duration adjuvant chemotherapy regimens for the treatment of breast cancer. The clinical health states are defined by the following three outcomes: (1) end of treatment toxicity, (2) disease recurrence, and (3) death. The results allow one to evaluate the trade-off between the increased toxic effects and the increased recurrence-free interval associated with the long duration treatment.",
keywords = "Clinical trials, Quality of life, Restricted means, Survival analysis, Utility",
author = "Gelber, {Richard D.} and Cole, {Bernard F.} and Shari Gelber and Aron Goldhirsch",
year = "1995",
doi = "10.1080/00031305.1995.10476135",
language = "English",
volume = "49",
pages = "161--169",
journal = "American Statistician",
issn = "0003-1305",
publisher = "American Statistical Association",
number = "2",

}

TY - JOUR

T1 - Comparing treatments using quality-adjusted survival

T2 - The q-twist method

AU - Gelber, Richard D.

AU - Cole, Bernard F.

AU - Gelber, Shari

AU - Goldhirsch, Aron

PY - 1995

Y1 - 1995

N2 - The quality of life of patients is an important component of evaluation of therapies. We present an overview of a statistical method called Q-TWiST (Quality-Adjusted Time Without Symptoms and Toxicity) which incorporates quality-of-life considerations into treatment comparisons. Multivariate censored survival data are used to partition the overall survival time into periods of time spent in a set of progressive clinical health states which may differ in quality of life. Mean health state durations, restricted to the follow-up limits of the clinical trial, are derived from the data and combined with value weights to estimate quality- adjusted survival. The methodology emphasizes treatment comparisons based on threshold utility analyses that high-light trade-offs between different health state durations; it is not intended to provide a unique result combining quality and quantity of life. We also describe three recent ex-tensions of the methodology: Covariates can be included using proportional hazards and accelerated failure time regression models, restricted estimates can be projected beyond follow-up limits using parametric models, and meta-analyses can be performed incorporating quality-of- life dimensions. The basic methods are demonstrated in an analysis of data from a clinical trial comparing long versus short duration adjuvant chemotherapy regimens for the treatment of breast cancer. The clinical health states are defined by the following three outcomes: (1) end of treatment toxicity, (2) disease recurrence, and (3) death. The results allow one to evaluate the trade-off between the increased toxic effects and the increased recurrence-free interval associated with the long duration treatment.

AB - The quality of life of patients is an important component of evaluation of therapies. We present an overview of a statistical method called Q-TWiST (Quality-Adjusted Time Without Symptoms and Toxicity) which incorporates quality-of-life considerations into treatment comparisons. Multivariate censored survival data are used to partition the overall survival time into periods of time spent in a set of progressive clinical health states which may differ in quality of life. Mean health state durations, restricted to the follow-up limits of the clinical trial, are derived from the data and combined with value weights to estimate quality- adjusted survival. The methodology emphasizes treatment comparisons based on threshold utility analyses that high-light trade-offs between different health state durations; it is not intended to provide a unique result combining quality and quantity of life. We also describe three recent ex-tensions of the methodology: Covariates can be included using proportional hazards and accelerated failure time regression models, restricted estimates can be projected beyond follow-up limits using parametric models, and meta-analyses can be performed incorporating quality-of- life dimensions. The basic methods are demonstrated in an analysis of data from a clinical trial comparing long versus short duration adjuvant chemotherapy regimens for the treatment of breast cancer. The clinical health states are defined by the following three outcomes: (1) end of treatment toxicity, (2) disease recurrence, and (3) death. The results allow one to evaluate the trade-off between the increased toxic effects and the increased recurrence-free interval associated with the long duration treatment.

KW - Clinical trials

KW - Quality of life

KW - Restricted means

KW - Survival analysis

KW - Utility

UR - http://www.scopus.com/inward/record.url?scp=21844481778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21844481778&partnerID=8YFLogxK

U2 - 10.1080/00031305.1995.10476135

DO - 10.1080/00031305.1995.10476135

M3 - Article

AN - SCOPUS:21844481778

VL - 49

SP - 161

EP - 169

JO - American Statistician

JF - American Statistician

SN - 0003-1305

IS - 2

ER -